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Aims and objectives: While haemodialysis is an effective treatment for end-stage
renal disease, the requirements and restrictions it imposes on patients can be oner-
ous. The aim of this study was to obtain UK National Health Service patients’ per-
spectives on the challenges arising from haemodialysis with the intention of
identifying potential improvements.
Background: Depression rates are particularly high in those with end-stage renal
disease; however, there is limited insight into the range of stressors associated with
haemodialysis treatment within the National Health Service contributing to such
high rates, particularly those of a cognitive or psychological nature.
Design: A qualitative approach was used to obtain rich, patient-focused data; one-
to-one semi-structured interviews were conducted with twenty end-stage renal dis-
ease at a UK National Health Service centre.
Methods: Patients were interviewed during a typical haemodialysis session. The-
matic analysis was used to systematically interpret the data. Codes were created in
an inductive and cyclical process using a constant comparative approach.
Results: Three themes emerged from the data: (i) fluctuations in cognitive/physical
well-being across the haemodialysis cycle, (ii) restrictions arising from the haemodial-
ysis treatment schedule, (iii) emotional impact of haemodialysis on the self and
others. The findings are limited to predominantly white, older patients (me-
dian = 74 years) within a National Health Service setting.
Conclusions: Several of the experiences reported by patients as challenging and dis-
tressing have so far been overlooked in the literature. A holistic-based approach to
treatment, acknowledging all aspects of a patient’s well-being, is essential if optimal
quality of life is to be achieved by healthcare providers.
Relevance to clinical practice: The findings can be used to inform future interven-
tions and guidelines aimed at improving patients’ treatment adherence and out-
comes, for example, improved reliable access to mental health specialists.
K E YWORD S
chronic kidney disease, haemodialysis, psychological well-being, psychology, qualitative study
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2017 The Authors. Journal of Clinical Nursing Published by John Wiley & Sons Ltd
Accepted: 29 April 2017
DOI: 10.1111/jocn.13871
J Clin Nurs. 2017;1–12. wileyonlinelibrary.com/journal/jocn | 1
1 | INTRODUCTION
Haemodialysis (HD) is a crude instrument. While it can prolong life,
it is unable to replicate the complexities of the human renal sys-
tem. Its requirements in terms of time and proximity to a specific
treatment centre begin immediately and continue without respite.
Patients endure physical distresses associated with HD, such as
fatigue (Liu, 2006), pain (Verhallen, Kooistra, & van Jaarsveld,
2007), restrictions to food and fluid intake (Baraz, Parvardeh,
Mohammadi, & Broumand, 2010) and reduced physical activity
(Johansen et al., 2000). Its constraints impinge on holidays, social
activities, employment and socio-economic status (Chilcot, Well-
stead, Da Silva-Gane, & Farrington, 2008; Norris & Agodoa, 2005;
Rodriguez et al., 2007). Evidence also indicates a detrimental
impact on marital and family relationships (Soskolne & De-Nour,
1987). Depression rates are high among end-stage renal disease
(ESRD) patients (Kalender, Ozdemir, Dervisoglu, & Ozdemir, 2007;
Martin, Tweed, & Metcalfe, 2004) but studies demonstrating rates
increase with duration of HD suggest that poorer psychological
well-being may be better explained by the challenges arising from
the HD treatment regime than the actual disease (Kimmel, Thamer,
Richard, & Ray, 1998; Lopes et al., 2002). In laboratory studies of
cognition, ESRD has been associated with multiple impairments
(Hart & Kreutzer, 1988), for example, of visual attention (Etgen
et al., 2009), executive functioning (Jassal, Devins, Chan, Bozanovic,
& Rourke, 2006) and psychomotor speed (Griva et al., 2003). In
addition, various aspects of memory have been shown to be
impaired: verbal and visual memory (Elias et al., 2009; Kurella,
Chertow, Luan, & Yaffe, 2004), working memory (Buchman et al.,
2009), episodic memory (Thornton, Shapiro, Deria, Gelb, & Hill,
2007) and conceptual memory (Jones et al., 2015b). However, it is
uncertain whether patients are aware of these impairments, and
to what extent they impact on everyday life. There are also
suggestions that cognitive performance fluctuates around the HD
schedule, but the evidence for this is mixed. Thus in the study of
Griva et al. (2003), patients were tested once immediately preced-
ing and once 24 hr after dialysis. The authors reported significant
improvements in attention, concentration, verbal and visual memory
and psychomotor speed, postdialysis. In contrast, Murray et al.
(2007) examined patients global cognitive functioning at four differ-
ent times around a dialysis session: 1 hr before, 1 hr into a session,
1 hr after and the following day. The authors found that cognitive
performance was worst during dialysis, with performance improving
1 hr after dialysis. Patients performed at their best 1 hr before and
the following day after dialysis, with no significant difference
between the scores at these times, unlike in the study of Griva
et al. 2003. It is not clear at present why this difference between
studies arose.
Several studies have used qualitative methods to explore aspects
of the impact of ESRD from the patient’s perspective. Examining
factors underlying the patient’s choice of treatment, Morton, Devitt,
Howard, Andersson, Snelling, & Cass, (2010a) and Morton, Tong,
Howard, Snelling, & Webster, (2010b) find a strong focus on
autonomy with overtreatment as opposed to effectiveness of treat-
ment or life expectancy being key. Ashby et al. (2005) describe the
factors which influence some patients to stop treatment altogether;
these include impaired quality of life and the desire not to burden
others. In a Swedish study, the main areas of reported suffering
came from the loss of freedom involved in HD and the dependence
on caregivers (Hagren, Pettersen, Severinsson, Luetzen, & Clyne,
2001). Patients felt that their lives were restricted by the need for
HD and that it consumed much of their time. They also felt that
there was an emotional distance between themselves and the doc-
tors and nurse caring for them and experienced a feeling of vulnera-
bility (Hagren, Pettersen, Severinsson, Luetzen, & Clyne, 2005). The
theme of inability to communicate effectively with staff in renal
units, both before dialysis started (and so its burdens came as a
shock) and later in treatment when patients’ health may have deteri-
orated, emerged in a UK study (Bristowe et al., 2015). In a Greek
study (Theofilou, Synodinou, & Panagiotaki, 2013), data from semi-
structured interviews indicate that HD is associated with unemploy-
ment, functional disturbance, nonadherence to medication and diet,
social isolation, fatigue, psychological distress and sexual dysfunc-
tion. Moreover, they reveal implications that may not be considered
by clinicians, for example, the social isolation experienced as a result
of HD scheduling constraints. Some of the findings may be specific
to the Greek healthcare system, which has been adversely affected
by recent austerity measures (Karamanoli, 2011), and to cross-cul-
tural differences in other studies. Nevertheless, loss of freedom,
sometimes poor communication between professionals and patients,
and (potentially serious [Denhaerynck et al., 2007]) nonadherence to
treatment are also found among National Health Service (NHS)
patients (Karamanidou, Weinman, & Horne, 2014). Spiers and Smith
(2016) also highlight the accompanying stressors associated with
waiting for a kidney transplant (a position that many HD patients
are in). The main stressors identified include the uncertainty of wait-
ing for a kidney and receiving a transplant from a living donor;
patients reported that these lead to an additional sense of confusion
and worry alongside the HD treatment process itself. It is notewor-
thy that a recent review of studies of quality of life in ESRD (Joshi,
2014) concluded that many relevant domains were currently omit-
ted, including thinking, learning, memory concentration, patients’
feelings about their health, dependence on treatments and the
What does this study contribute to the wider
global clinical community?
• Provides a comprehensive understanding of the physio-
logical, emotional, social and psychological challenges
faced by haemodialysis patients in the UK National
Health Service (NHS).
• Highlights areas of patient care in which future interven-
tions could be targeted to improve treatment adherence
and patient outcome.
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financial burden of treatments. A related point was made by Morris,
Biggerstaff, and Lycett (2016), who urged that listening to patients’
voices is important in plans for improving renal health care.
The aim of this study was to better understand some of the chal-
lenges faced by ESRD patients undergoing thrice-weekly HD in a
hospital-based renal unit, especially those noted by Joshi to be omit-
ted from most studies of ESRD. A qualitative approach was selected
because it provides rich, meaningful, patient-focused data. It enables
problematic and/or distressing aspects of HD, perhaps overlooked
by clinicians, to be identified and delineated. It has been used effec-
tively for this purpose with other chronic illness populations, namely
cancer (Ashing-Giwa et al., 2004), diabetes (Rubin & Peyrot, 1999),
stroke (Lynch et al., 2008) and dementia (Steeman, Casterle, Dierckx,
Godderis, & Grypdonck, 2006). Qualitative studies investigating the
impact of ESRD have provided substantial, useful data; however,
because one of the aims of qualitative research was to provide
understanding of the meanings and interpretations of behaviour
within the specific sample under study, it is of value to conduct fur-
ther qualitative research with additional samples in order to establish
the extent to which similar themes emerge and new themes are
revealed. In this study, we were particularly interested in the fluctua-
tions in cognitive abilities caused by HD, reported to us by patients
in quantitative studies of cognition (Jones, Butler, Harris, & Vaux,
2015a; Jones, et al., 2015b). In addition, this study aims to provide
an understanding of the patient experience in the UK NHS. Being
the largest and oldest publicly funded healthcare system in the
world, the NHS is a unique facility and, although many experiences
are likely to be shared across other healthcare settings, due to the
scale and composition of the organisation, there may be some
issues/concerns that are specific to the NHS.
2 | METHODS
The study was approved by an NRES Committee and by a University
Research Ethics Committee and was conducted by the principal
investigator (PI) who designed the study, conducted the interviews
and coded the data. The study was designed and conducted in line
with Guba and Lincoln’s criteria for rigour in qualitative research
(Denzin & Lincoln, 1994) and reported using the COREQ checklist
(Tong, Sainsbury, & Craig, 2007).
2.1 | Design
For this study, one-to-one semi-structured interviews were con-
ducted with ESRD patients, and the data were analysed using con-
tent analyses. ESRD patients were recruited from two renal NHS
units located in the UK. One unit is an in-hospital dialysis centre
located in a large general hospital. The other unit is a dialysis-only
unit located at a single site independent from any hospital. All
patients were receiving thrice-weekly HD for 3–5 hr per treatment
and had been receiving HD for a minimum of 90 days prior to test-
ing (adequate dialysis at Kt/v > 14). All patients meeting these
criteria (n = 60) were sent an invitation letter from their consultant
nephrologist outlining that the purpose of the interview was to gain
an insight into how dialysis patients manage their treatment and the
effects it has on daily activities. The PI met patients once they had
expressed an interest in the study. At this meeting, PI described that
the research was part of a doctorate thesis examining the impact of
renal disease on cognition and quality of life, and explained the
study in greater detail. PI interviewed all those who agreed to partic-
ipate, providing a consecutive sample. As well as being practical, this
approach maximised the diversity of the sample by enabling any
patient meeting the criteria to participate. Interviews were con-
ducted with 20 patients: eight male and 12 female whose ages ran-
ged from 55–88 years with a median of 74. One of the 20
interviews was terminated prematurely due to the interviewee feel-
ing unwell. No one approached declined to participate. Towards the
end of interviewing, the researcher noted that little new data were
appearing and concepts were well developed (theoretical saturation).
Several additional interviews were conducted to confirm this impres-
sion. Given that consecutive sampling had maximised participant
diversity, and that the data obtained had been systematically com-
pared within and between participants, the researchers judged that
after the twentieth interview, sufficient data had been collected to
address the research question.
2.2 | Data collection
Individual semi-structured interviews were conducted by the PI fol-
lowing training from an experienced qualitative researcher. Written
informed consent was obtained prior to interview. Interviews were
conducted at the bedside during a typical HD session. The location
of interviews is important in qualitative research as no setting is
truly neutral and all settings shape the data. The bedside was
selected because it was convenient for both researcher and patient,
and because it avoided attrition. Its disadvantages were that patients
may have felt inhibited by the presence of other patients and health-
care practitioners, or perceived the research to be connected to
treatment. The researcher was careful to ensure patients consented
to being interviewed at the bedside and that they could not be over-
heard. The researcher also explained that the research was not con-
nected to treatment. However, it is acknowledged that patients’
accounts were influenced by the setting. A topic guide (see
Appendix A) comprising twelve open-ended questions was used; it
was developed from a review of ESRD literature and from informal
conversations with patients and nursing staff on an NHS dialysis
ward. Patients were informed that the researcher was not part of
the clinical team and was interested in understanding the impact of
HD on all aspects of the patient’s life, for example: “Do you find
there are tasks, which are quite familiar to you, that you find more
difficult now than before you were ill?” and “How would you rate
your overall memory?” The topic guide was used flexibly, and the
interviewer used prompts and probes to encourage patients to
expand and elaborate on topics, and to introduce any additional con-
cerns or issues they considered relevant. Each interview lasted
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between 13–42 min (median length: 23 min) and was stopped when
patients felt they had nothing further to add. Interviews were audio-
recorded and transcribed verbatim. Detailed field notes were kept.
2.3 | Data analysis
Transcripts were analysed using the Atlas.ti v.7 software package
(Atlas.ti Scientific Software Development GmbH, Berlin, Germany).
Thematic analysis was used to group common ideas across tran-
scripts allowing generation of higher and lower codes (labels repre-
senting an idea or theme). A systemised approach to coding was
used (Fereday & Muir-Cochrane, 2006), and the principals of the
constant comparison Method in which data are coded and re-coded
iteratively and inductively were employed (Strauss & Corbin, 1994).
Coding began by noting and grouping common patterns, themes or
metaphors that encapsulated general ideas. Next, initial codes were
revised and regrouped to create more definitive groups, which pri-
marily involved making further connections between different cate-
gories or topics. Finally, common categories were finalised and
unified around a central theme. Quotes were then identified and
linked to the appropriate unifications to form clusters of quotes to
represent codes. The quotes presented in results section were drawn
from these clusters and selected because they best represented a
code or illustrated different aspects of a code. Codes were then
combined to generate families of co-occurring ideas or similar over-
arching themes. For example, the codes “predialysis problems,”
“postdialysis problems” and “problems during dialysis” were united to
form the family called “fluctuations in cognitive and physical well-
being across the dialysis cycle.” Coding was undertaken by the PI
and discussed with several other researchers so that internal thinking
processes were made explicit, ideas clarified and new insights
obtained.
3 | RESULTS
Three distinct themes emerged from the data:
1. Fluctuations in cognitive and physical well-being across the HD
cycle.
2. Restrictions arising from the HD treatment schedule.
3. Emotional impact of HD on the self and others.
3.1 | Fluctuations in cognitive and physical well-
being over the dialysis cycle
Cognitive fluctuations were classified as problems with mental pro-
cesses such as fluidity of thought, concentration and memory,
whereas physical fluctuations were classified as somatogenic symp-
toms such as pain or fatigue. Multiple patients expressed concerns
about their memory; many described poor short-term memory,
specifically remembering to carry out day-to-day tasks. A commonly
described occurrence was the inability to accurately remember
names of people from the past and new people they had interacted
with on the ward (e.g., nurses):
P4, male, 56 years: “. . .I think my memory is not as
good as it was three plus years ago; generally it’s not
quite as good.” and “. . .it has been a concern a bit that,
you know, some things I think, “Oh I should have
remembered that, such and such” and you don’t, some
people’s names.”
One patient explicitly associated their memory loss with their HD
treatment but the majority attributed it to old age or medication. Few
believed their memory problems fluctuated with the dialysis schedule,
describing general, rather than time specific, memory deficiency:
P4, male, 56 years: “I suppose regularly after dialysis not
being with it as much, I suppose my memory is almost,
it becomes lazy. Err, yeah, it’s probably a bit worse, it’s
almost certainly worse after dialysis.”
P8, male, 84 years: “My memory has, normally due to
my age I think my memory has lost a bit, lost a bit of its
sharpness. I don’t remember things very well, and err,
but the dialysis hasn’t changed that.”
However, several described an impact on their physical and cog-
nitive health. This appeared to be irrespective of age. Three distinct
groups emerged:
A. Patients who were physically and cognitively fatigued by HD.
B. Patients who were physically but not cognitively fatigued by HD.
C. Patients who were unaffected by HD.
For patients in Group A, there was a notable difference in well-
being between dialysis and nondialysis days. These patients reported
mental fatigue, drowsiness, tiredness, light headedness and a lack of
concentration and motivation after a typical dialysis session, which
resulted in them being unable to undertake simple day-to-day activi-
ties and had an impact on employment. P1 described the effect as
that of “. . .a fly being swatted. . .you feel dopey” (P1, female,
73 years). Patients in this group quite often reported wanting to
sleep after dialysis rather than engage in anything more cognitively
demanding such as reading or completing a crossword. Two patients
reported a disruption to their fluidity of thought, impairing conversa-
tions with nurses and transport staff. The cognitive and physical
impact of HD was especially problematic for this group of patients if
they were dialysed in the morning, several of whom described a feel-
ing of “wasted days”:
P1, female, 73 years: “Well you’re a bit dopey if you
know what I mean. I come off far dopier than I went on,
which to a certain extent annoys you, because I come
here to have this treatment but I feel worse when I have
4 | JONES ET AL.
it.” and “. . .I don’t want to concentrate, I don’t want to
be bothered, you don’t want to be bothered, I just want
it shut off, I just sit in my chair and go to sleep.”
P6, female, 82 years: “. . .go down and the bus drivers
start chatting, “Oh, you alright?”, and I can’t think of an
answer, because the brain doesn’t work, it just sort of,
everything has gone from you. You’re just a person.”
Patients in Group A typically reported their cognitive functioning
was restored to normal, and their physical tiredness greatly reduced,
by the day after HD. Indeed, nondialysis days were generally
regarded as better for their cognitive and physical well-being, and an
opportunity to carry out activities or socialise. However, this type of
reaction was not unique to Group A patients but was also observed
in Group B patients:
P11, male, 77 years: “Oh the best time is the day after
dialysis when you’ve got a free day, or the weekend. . .”
The distinctive feature of Group B patients was that the physical
fatigue experienced following HD was not accompanied by an
impact on cognitive functioning. Like those in Group A, when
patients in Group B returned home following treatment most wanted
to sleep and found activities such as watching television or reading
resulted in falling asleep. They were also unable to undertake activi-
ties or socialise postdialysis. Unlike Group A patients, they perceived
this as a physical, not cognitive, response to HD:
P8, male, 84 years: “No, I feel generally physically tired,
that’s all. But mentally I am alright”
P5, female, 66 years: INT: “You feel mentally fatigued as
well?”, P: “No, not really, just overall tiredness. By about
8 o’clock tonight I’ll be back to sleep, that’s my day gone
really.”
As with Group A, by the day following HD, Group B patients
were more alert and could undertake normal daily activities. In con-
trast to Group A and Group B patients, Group C patients reported
no effect on their cognitive or physical functioning following HD.
Consequently, their accounts do not feature the perception of HD
as being restrictive or time-consuming, as commonly described by
Group A and Group B patients:
P18, male, 75 years: “I don’t notice any difference from
when I come on dialysis to when I go off dialysis.”
P3, female, 59 years: “And normally when I get home I
can do just about anything, you know, and if I start to
feel a little bit funny I’ll drink something and just replen-
ish the fluid a little bit.”
The emergence of three distinct groups demonstrates the
heterogeneity of HD patients postdialysis and provides a better
sense of the variation between individuals within a single treatment
system. Of note is the different post-treatment capacity that
patients report with some able to engage with a healthcare profes-
sional after HD, whereas for others this is too challenging.
The general consensus of the sample was that the time period
immediately preceding dialysis is one of optimal well-being—it is the
treatment procedure itself that causes a decrease in well-being.
Patients typically stated that they felt no different in advance of
dialysis, for example: “No, no. It’s just like a normal day, the only dif-
ference is I come for dialysis instead of go out shopping.” (P15, male,
70 years). An alternative perspective was provided by a handful of
patients who described feeling adverse effects of a long period with-
out dialysis. While they were unable to articulate the feeling pre-
cisely, they described feeling below par. However, there was no
discernible pattern to this response; patients reporting these predial-
ysis experiences did not correspond to any specific postdialysis
group (A, B or C). This suggests that there may be greater hetero-
geneity pre-HD compared to the post-HD experience:
P4, male, 56 years: “Sometimes on a Monday, following
a weekend without the dialysis, I feel almost as if I’m
needing the dialysis. I don’t know if it’s psychological or
physiological, or a bit of both, but I feel it’s time; I need
to have it done.” and “it starts on the Sunday really, um,
the day before I have dialysis, at about mid-afternoonish
I start to feel yes it would be a good idea to have dialy-
sis. . .”
P4, male, 56 years: “On a score out of ten, I would say
8 out of 10 now [on dialysis], compared with, as I said
about the Sunday, starting to feel as though you need
dialysing, that’s probably about 2 to 3 out of 10.”
3.2 | Restrictions arising from the HD treatment
schedule
A second theme that emerged from interviews was the practical limi-
tations arising from HD. Many patients commented on the stress
caused by the various requirements of HD, the time-consuming nat-
ure of dialysis (upwards of 14 hr per week) and the permanency of
the treatment process without a definitive endpoint. The combina-
tion of these factors is unique to patients receiving HD.
The most common restriction patients reported related to holi-
days and going on vacation. At one stage or another, all were pre-
vented from travelling or going on holiday (either abroad or in the
UK) by their treatment regime, and almost all commented that this
had an impact on their psychological well-being, causing frustration
and in some cases despondency:
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P6, female, 82 years: “Oh yeah, and I think that’s why I
am probably depressed because I’m not getting a holi-
day. I haven’t had a holiday for three years.”
P5, female, 66 years “Well that is frustrating, cos we
used to go away, at least once a year abroad, and
course can’t do that now, so I can’t get no sunshine.”
Some patients expressed disappointment about the impact of
HD on their retirement plans (the majority of patients in the sample
were approaching retirement age or already retired). They described
anticipating their retirement as a time to undertake longed-for activi-
ties, but finding the restrictions associated with HD made those
aspirations unattainable:
P4, male, 56 years: “Oh and before I had this condition I
thought that when I retired I would do a lot of travelling
and all that sort of thing, um, that’s out of the picture,
that’s not going to happen.”
A specific restriction, mentioned by the majority of participants,
related to diet. If patients’ salt, glucose, alcohol, fluid intake and
exercise are not controlled, “fluid overload” can ensue, resulting in
breathlessness, swelling and hypertension, potentially leading to car-
diovascular problems and possible death (Franz, Pohanka, Tribl,
Woloszczuk, & H€orl, 1997). Between dialysis sessions, patients are
given tailored programmes specifying fluid, food and sodium intake.
Their weight is monitored before and after dialysis sessions, and
they are required to monitor their dietary intake constantly and
without respite. They are unable to indulge even occasionally and
are advised not to drink alcohol. The majority of patients described
eventually acclimating to these restrictions, although most found
doing so difficult:
P11, male, 77 years: INT: “Your diet is quite restricted?”
P11: “Yeah that was initially a problem but I seem to
have got the mental adjustment to it now, like not to
drink too much. . .”
However, a minority responded differently to the dietary restric-
tions recommended. These patients confessed to ignoring the guid-
ance of their treating dieticians and following their own diet.
P2, female, 69 years: “Supposed to be yeah, but I’m
afraid most of the time I ignore it. Most of the foods
they recommend in here I don’t like. So I don’t stick to
my diet very well, which the doctor doesn’t like.”
While the long-term impact of this decision is probably detrimen-
tal to physical health outcomes (Morduchowicz et al., 1993), exercis-
ing this freedom of choice appeared to have some benefits for
patients in terms of reduced stress:
P18, male, 75 years: “Well they do tell you in here
because there’s a dietician, don’t have this and don’t
have that. No, I have a normal diet to be honest and it
works.”
A major concern spontaneously voiced by many participants was
the restrictions arising from NHS provided transport to and from
their dialysis sessions, which was described as frequently and some-
times substantially delayed. For patients, this meant already long
treatment sessions were further extended. For example, P14
reported that on one occasion, following dialysis lasting several
hours, they had to wait a further 2 hr for his transport home, culmi-
nating in a treatment session lasting 8 hr. Participants reported
anger and frustration at about the time-consuming transport delays,
particularly as they further curtailed already restricted days, increas-
ing stress:
P13, female, 80 years: “And sometimes you have to wait
quite a while, it’s the waiting that’s the trouble, you
know, you feel tired and just want to go home and you
have to wait around for somebody who’s not finished.”
P15, male, 88 years: “Sometimes we have to wait a hell
of a time for it. One classic night there was three of us,
live near each other, we were all picked up together, we
had to wait until 7 o’clock, and er, not happy about
that. It lengthens your day and you’re fed up and you
think “Why are we waiting here?” and there’s no real
answer.”
P16, female, 63 years: “Sometimes I finish at half 4,
then I have to wait until quarter to 6. Again I’m a very
impatient person, by then I am always angry.”
Sacrificing employment or job opportunities because of HD was
common among patients, whether it was retiring, working part-time
or limiting working hours to fit in with the dialysis schedule. For
those patients still employed, this had a financial impact, but impor-
tantly was also described as a challenge to their work ethic:
P4, male, 56 years: “So, yeah, the spin-off will affect my
income, which in a way I feel a bit grieved about, I don’t
think it should, but it’s going to. But I can’t, I don’t think
I can do too much about it. But I’m talking with them at
the moment, so we’ll see how it goes.”
Retirees expressed frustration at not having the freedom to com-
plete chores and undertake daily activities such as housework and
gardening. They frequently commented that HD restricted the
amount of time they have to undertake such jobs; the more severely
affected patients had only four available days per week; partly due
to HD, but also because of the adverse effects of treatment. In addi-
tion to restricting the time available for daily chores, patients also
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described HD as restricting their time available for socialising. Con-
sequently, patients considered their usable time had become more
valuable and sacred:
P4, male, 56 years: “It is wasting my life, every Monday,
Wednesday, [and Friday] I certainly wouldn’t go to eve-
ning classes, definitely wouldn’t, wouldn’t touch it with a
barge pole. I used to occasionally go to evening classes
over my lifetime, but not after dialysis, there’d be no
point, I get absolutely no enjoyment, I’d hate being there,
and I probably wouldn’t remember a lot. There’d be
absolutely no point, be a waste of money.”
P1, female, 73 years: “Cos you do, well you got no life,
you might think it’s coming in having it, but it’s not you
haven’t got no life. You have, 3 days a week, then doc-
tors’ appointments, one Dr, this Dr, that Dr, you’re liter-
ally being pulled apart if you know what I mean.”
Once again, these examples demonstrate the variability across HD
patients, in that stressors are very much dependent upon the lifestyle
expectations of individual patients. However, what is apparent across
the group is the consistent reports of frustrations and unhappiness at
the overall impact that treatment has upon their quality of life.
3.3 | Emotional impact of HD on the self and others
A third theme that emerged from the interviews was the impact of
HD on patients’ emotional health and the impact this had on rela-
tionships. Patients described being unable to spend as much time
with family members and friends as they wished, in addition to the
strain on relationships arising from the restrictions of the treatment
schedule:
P4, male, 56 years: “My daughter lives over in South
Wales. You know, I’m a bit wary; I wouldn’t go and
spend a few days there because I’ve got dialysis here. I
know you can arrange things, but I don’t really want to
be going through that palaver in doing that, so perhaps,
I don’t know, I see her less because of this, but if I do
take this slightly early retirement the opportunity to see
her more won’t necessarily go up as more as if I hadn’t
been on dialysis, so that’s another issue.”
P11, male, 77 years: “. . .cos I’ve got a lot of friends
scattered around the place and I don’t get to see them.”
Patients also reported concern that their HD was a constant
worry and stress for their family members. Typically, clinicians and
support groups focus on the impact of HD on patients, but this
study highlights the considerable impact the disease, and treatment,
has on their family, in particular the practical and emotional strain
placed on them and the impact on their psychological well-being:
P17, female, 70 years: “Well my husband sorts out all my
medication, drives him mad it does because I’ve got so
much different stuff that I take, and er, he does that night
and day. He looks after me in the house as well. . .”
P12, female, 79 years: “My husband couldn’t take it in, I
don’t think he can now; he goes to pieces if anything
unforeseen happens to me.”
P7, female, 81 years: “I feel a bit sorry for my husband
because, you know, he probably would have to like to go
to Greece or something, we’ve been there a few times.”
Throughout the interviews, patients frequently described an
emotional response to specific aspects of HD, for example, the
depressing effect of restrictions to travel, but beyond these, there
was a more overarching emotional response. Numerous patients dis-
cussed feelings of helplessness, describing themselves as victims of
the treatment, rather than the treatment benefiting them. Many
patients described themselves as being in a fragile emotional state
due to the physical and emotional demands of treatment, and sev-
eral reported depression and resentment. Patients reported wanting,
on occasion, to abandon treatment because it was so challenging to
persevere with it week after week:
P2, female, 69 years: “. . .actually 2 weeks ago I was on
the verge of giving it up, I didn’t want to do dialysis any-
more. My family nagged me and now I am back on dial-
ysis. I resent the fact that. . .before I came on dialysis
they said: “Once you’re on dialysis you will feel fine, you
won’t know you’ve got kidney problems, you’ll feel fine.
They lied to me, they don’t know because they are not
on dialysis. It does affect you, it affects your life. You
get very depressed.”
P1, female, 73 years: “They said well, they more or less
said to me every year about you’re going to die, but I have
told them I don’t want to do this for the rest of my life, I
know it might be only 7–10 years at the most, I just don’t
want to do it. I don’t want to do this for the rest of my life.
I just, I just can’t explain it, it’s just not nice, you feel like
your body is being invaded, all the time.”
P2, female, 69 years: “I just resent being on dialysis, I
just don’t want to be here. If someone said I could go
now I would go. I suppose because it’s changed my life I
resent it. The fact that I’m on dialysis 3 days a week
four hours a day.”
The longevity of HD treatment was exposed as a major factor in
patients’ emotional state. Patients reported that one of the hardest
parts of the treatment process is the multiple unknowns: they do not
know how long the treatment will last, whether they will ever be rid of
HD and whether they will ever get a transplant. Consequently, they
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viewed HD as a never-ending process from which they could not
escape, which lead to feelings of frustration, resentment and depres-
sion:
P6, female, 82 years: “But I just like my freedom, and it
just ties you down completely. And I wouldn’t mind if
there was some end, say in three years’ time or so you’ll
be free, but it’s just the rest of your life.”
P2, female, 69 years: “Well yeah, I got a good lecture off my
family and Jean told me off. Couldn’t see. . .I just thought
why am I still coming here, I’m not going to be better in
6 weeks’ time or 6 months’ time, I’ll still have it. I will proba-
bly be worse than what I am now; can’t see an end to it.”
While many patients were negative towards HD several tried to
focus on its positive aspects and, by acknowledging the alternative
to HD was death, these patients appeared able to achieve a degree
of acceptance. For some patients, age contributed to their more
positive outlook: these patients described feeling gratitude for the
life they had had, and viewed HD as enabling them to further
extend it:
P9, female, 87 years: “For me, I’m 87 this year, so there is
no transplant or anything. So that is true, so you must
help yourself by listening to what you are told and learning
about yourself as much as you can, but you’ve got to
understand your body and understand your illness, and to
listen to what you are told and do your very best.”
P7, female, 81 years: “. . .what you have got to think of
is this is keeping me alive; I’d be dead, I mean years ago
a lot of people died if you had kidney failure. So umm,
I’m very pleased in that respect.”
P8, male, 84 years: “In the beginning yes until I got used
to it, I am quite used to it now, I am happy to come. I
come here three times a week and it consumes, the
day’s absolutely lost. I start at 12.30 and finish at 5.30–
6.00, so the day is gone.”
Having considered themes individually and in-depth, we then con-
sidered the relationships between them. The three themes described
the effect of HD on distinct and specific aspects of patients’ lives, but
together, they also reflect the cumulative nature of these stressors.
Although stressors are personal, based partly on age and lifestyle, their
collective impact was shared among all patients. In particular, patients
described how the impact of HD on one aspect of life encroached on
other aspects of life, for example, one patient reflected how the inabil-
ity to be spontaneous affected their emotional health:
P6, female, 82 years: “Umm, also you find it difficult when
you’d love to say “Oh yes I’ll go off to get the bus to New-
bury”. But you can’t do that I’m at RBH tomorrow for
dialysis. And that sort of gets depressing, makes you
depressed.”
The cumulative and encroaching impact of HD on one’s well-
being was summed up by P4:
P4, male, 56 years: “It affects spouse, one’s spouse. It
affects so many different things, and those all have a
depressing effect.”
3.4 | Summary of key findings
1. Fluctuations in cognitive and physical well-being across the HD
cycle: In terms of the cognitive and physical effects of the treat-
ment, patients have a heterogeneous experience of HD. This
investigation highlights the variation in patient experience;
healthcare staff are unable to provide support with a one-size-
fits-all approach.
2. Restrictions arising from the HD treatment schedule: Irrespective
of age and lifestyle, restrictions, particularly relating to vacations,
work and transport, have a considerable negative impact on
patient quality of life.
3. Emotional impact of HD on the self and others: An often over-
looked issue, HD puts a considerable strain on personal relation-
ships, and consequently impairing patient quality of life. Patients
described feelings of helplessness, viewing HD as detrimental to
their overall well-being, with several patients stating episodes of
depression and resentment towards the treatment.
4 | DISCUSSION
Semi-structured interviews were conducted with twenty patients
with ESRD receiving thrice-weekly HD at NHS centres. Three core
themes emerged which described (i) the impact of HD on patients’
cognitive and physical well-being, (ii) the restrictions arising from the
treatment schedule and (iii) the emotional impact of HD on the self
and others.
Fluctuations in physical and mental well-being coinciding with
the schedule of dialysis treatment were reported by many patients.
Although fluctuations in physical comfort have been associated with
fluid levels over the course of the dialysis cycle (Jaeger & Mehta,
1999), the implications and exact manifestations of this discomfort
have yet to be fully explored. Although others have noted that some
patients experience unpleasant symptoms at the end of a dialysis
session (Karamanidou et al., 2014), this study is the first to identify
categories of response to HD; three distinct groups, consistent in
their differences over time, emerged from the data (physically and
mentally affected, only physically affected, unaffected), demonstrat-
ing the range of patient demands, within one treatment setting, that
renal healthcare professionals need to be aware of. Further research
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is required to determine whether these categories are generalisable
to the broader population of patients. If they are, clinicians may be
able to use them to predict which patients are more susceptible to
adverse physical and mental effects and so target additional support,
perhaps by tailoring patients’ HD schedules and avoiding early HD
sessions for patients adversely affected. The existence of subgroups
of patients whose performance may be affected differently by dialy-
sis suggests one possible explanation for the inconsistency in the
studies of the effects of HD on cognition. Clearly, if the majority of
patients in a study are those who have reported no effects or only
physical effects of dialysis, then the chances of finding an effect on
cognition are reduced. The reasons why patients are differentially
affected by HD are not clear. Biochemical changes have been
suggested as one explanation for such differences; a study by Griva,
Thompson, Jayasena, Davenport, Harrison, & Newman, (2006) found
weak correlations between neuropsychological performance and
biochemical measures. Madan, Kalra, Agarwal, and Tandon (2007)
also found a positive correlation between serum creatinine, blood
urea and uric acid with P3 latency (an early measure of processing
speed and thus cognitive impairment). Findings of this relationship
are somewhat limited though, and thus inconclusive. What is clear,
however, is that the reliable adverse effects of HD on the cognitive
state of some patients need to be taken into account when choosing
when to give important information about treatment.
Several aspects of our data echo the findings of other studies.
The most common concern among this group of patients with ESRD
related to the restrictions associated with HD. In many interviews,
patients described a typical dialysis week as arduous and resulting in
a loss of independence with the impact extending to partners and
family. Strict scheduling of HD prevents patients from having a regu-
lar job, impacting upon income and consequently the ability to sup-
port a family, as also found by Hagren et al. (2005). As in our study,
these authors also noted that the amount of time spent on dialysis
and adverse effects of treatment restrict the time available for daily
activities. Although small in isolation, the accumulation of such
restrictions has a detrimental effect on overall well-being and
patient’s quality of life. This study raises the awareness to clinicians
and healthcare managers that the restrictions patients face, while
seemingly minor, are accumulative. Demonstrating a greater under-
standing and willingness to find creative and bespoke solutions,
where possible, is likely to have a positive impact. Patients need to
be acknowledged as experts in their illness and treatment. They
should be supported to identify effective ways in which they might
cope with the impacts of HD specific to them. Time needs to be
taken to understand the specific challenges HD raises for individual
patients so that care can be tailored to better address their needs.
Petrie and Weinman (2012) advocate the idea of supporting patients
to fully comprehend their illness, and their perceptions towards it,
leading to better outcomes. The upshot for patients with ESRD
would be better treatment adherence, happier patients and carers
who can continue to lend support.
Dietary restrictions appeared to be particularly problematic,
such that some patients rejected clinicians’ advice, risking the
significant health implications of poor ESRD management (Kalantar-
Zadeh & Kopple, 2001; Locatelli et al., 2002). Others have noted
that this is especially problematic in the case of fluid intake when
patients become thirsty (Hagren et al., 2005). However, while
patients often confess to eating forbidden foods, skipping medica-
tion appears to be less deliberate (Karamanidou et al., 2014), more
likely a consequence of the cognitive deficits associated with ESRD
(Jones et al., 2015a). It is important for clinicians to be aware that
when patients perceive the restrictions on diet and fluid intake to
be unacceptably onerous, they abandon them. There is a need for
strategies to be developed that seek to improve patients’ perceived
control and ability to implement advice; once again, interventions
such as those advocated by Petrie and Weinman (2012), at chang-
ing perceptions, through guidance, to fully understand their illness.
A key issue that emerged from the data related to the NHS
transport system. A patient may take advantage of the free trans-
port provided by the NHS, but ever-increasing demands on the sys-
tem may mean a wait for transport to arrive. For patients who
already feel that their independence has been curtailed, the addition
of an avoidable (at least perceived) extended period in hospital
(sometimes for periods of 2 hr or more) as a consequence of delays
amplified frustration and anxiety. An Australian-based study (Mor-
ton et al., 2010a, 2010b) identified one of the negative perceptions
of hospital-based dialysis was the need to travel. A multinational
study, including the UK, conducted by Moist et al. (2008) suggested
that a longer one-way travel time to the dialysis centre contributed
to lower quality of life and a significantly greater risk of mortality
in patients. Given the impact of transport problems on NHS HD
patients, continued attempts to improve the service would likely
have a substantial positive impact on patients.
Personal relationships were noted as a significant factor influenc-
ing patient well-being. The reliance, worry and stress put on a family
carer can manifest as anger and frustration, significantly impacting
on patients. The extra burden of care on family members has been
seen by patients as a negative aspect of home-based dialysis (Mor-
ton et al., 2010b). Evidence suggests that the stresses of caring for
a relative can have a negative impact on the immune system, mak-
ing the carer more vulnerable to infectious diseases (Vedhara et al.,
1999). Alvarez-Ude, Valdes, Estebanez, and Rebollo (2003) found
that caregivers of patients on dialysis experienced a higher burden,
had a worse score on a quality of life measure (HRQOL) and had a
higher risk of clinical depression than the normal population of a
similar age. Auer (2002) suggests it is imperative to address the
carer’s needs, as well as the patient’s, as much of a patient’s time is
spent away from the hospital. If we are to consider patient welfare
holistically, with the end goal being optimum quality of life and pro-
longed life, then carer welfare is equally important in this equation.
Current estimations suggest that nine of 10 carers of HD patients
are close relatives and that the presence of a family carer improves
patients’ treatment adherence and compliance to dietary restrictions
(Cicolini, Palma, Simonetta, & Di Nicola, 2012). The cancer literature
highlights the importance of the practical, emotional and psychologi-
cal support that caregivers provide for patients (Thomas, Morris, &
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Harman, 2002) while the stroke literature suggests that family care-
givers often feel isolated and that their own needs are neglected,
leading to strains on the relationship (McKevitt, Redfern, Mold, &
Wolfe, 2004). It is important for clinicians and healthcare managers
in the renal setting to recognise the vital care relatives provide so
that they can be supported to continue in their caregiving role.
A dichotomy arose between patients that had a generally nega-
tive outlook and those who had a positive one; a possible explana-
tion being a patient’s subjective locus of control. Christensen,
Turner, Smith, Holman, and Gregory (1991) investigated the relation-
ship between locus of control and depression in patients with ESRD.
The extent to which patients believed that their health was control-
lable was directly linked to whether they had recently received a
failed transplant or not, with those that had experiencing greater
rates of depression than those who had not. The authors suggest
that perception of control contributes significantly to patient out-
come when dealing with patients with chronic illness. In this study,
those patients who viewed HD as a choice in order to prolong life,
and something that is under their control, generally tended to have a
more positive outlook. If control and autonomy, with relation to the
disease or treatment, can be addressed, then the benefit to patients’
emotional well-being may be considerable. Introducing brief in-hospi-
tal interventions that increase patients’ autonomy is likely to improve
the holistic experience of the treatment process, facilitating better
patient outcome. However, further investigations are required to
establish a clear association between locus of control and patient
outlook in the HD population.
The experiences described here are those of patients receiving
HD treatment within an NHS hospital setting, and therefore, some
of the concerns and issues raised may not be relevant for patients
receiving peritoneal dialysis or HD treatment in other institutions.
Furthermore, although a diverse sample of HD patients was sought,
the sample was predominantly white and over 70 years of age.
Although reflecting the typical patient receiving HD in an NHS set-
ting, the concerns of other groups may not have been captured. For
example, children receiving HD may have a different experience of
treatment compared to an older adult population. Further studies
using a similar methodology with other groups should be conducted
so that their experiences can be better understood.
5 | CONCLUSION
The use of semi-structured interviews enabled the discussion of a
broad range of issues directly relevant to HD patients. Some of
these issues, such as transport concerns and fluctuations in cogni-
tion, have so far been overlooked in the ESRD literature. By docu-
menting patients’ experiences in a systematic fashion, we can begin
to highlight areas that, if addressed, have the potential of a substan-
tial impact on patient welfare. However, as noted from this investi-
gation, this requires a clear, holistic approach, with a joint effort
from clinicians, care providers and healthcare managers. In addition,
investigations such as these can be used to educate new patients
who are na€ıve to the demands of HD treatment. It is clear that there
are patients in the NHS who, prior to treatment, were not made
aware of the internal and external stressors that accompany HD
treatment (P2, female, 69: “They lied to me, they don’t know
because they are not on dialysis. It does affect you, it affects your
life. You get very depressed”). Curtin and Mapes (2001) highlighted
education and self-management of treatment as essential tools to
improving overall patient well-being.
6 | RELEVANCE TO CLINICAL PRACTICE
The issues highlighted in this study are relevant to all those involved
in the treatment of ESRD in an NHS setting, including the HD
patients themselves. Through semi-structured interviews, patients
have provided a rich account of the practical and emotional chal-
lenges that accompany HD. The data suggest that a holistic approach
to treatment and care is required. Potential areas for improvement
have been identified, for example, the introduction of additional sup-
port networks, including the introduction of easy access to an estab-
lished psychology and/or social work service for all NHS patients.
These findings can be used to inform such future interventions and
guidelines, to establish a framework with the aim to improve patients’
holistic experience of HD, adherence to treatment and medication,
and overall outcome. Given the complexity of patients’ experiences,
and the heterogeneity of patient demands, further studies trialling
the feasibility and acceptability of such interventions are required.
One area of investigation may be to look at the role of perceived
control on medication and dietary adherence. Although the data were
gathered within an NHS setting, there is no obvious rationale for
why many of the suggestions for improvements in treatment could
not be applied equally to other healthcare systems.
ACKNOWLEDGEMENTS
Thanks to our participants and staff of the Royal Berkshire Hospital
and Windsor Dialysis Unit renal wards for their help and support.
CONTRIBUTIONS
Study design: DJ, JH, LB, EV data collection and analysis: DJ; and
manuscript preparation: DJ, KH, JH, LB, EV.
REFERENCES
Alvarez-Ude, F., Valdes, C., Estebanez, C., & Rebollo, P. (2003). Health-
related quality of life of family caregivers of dialysis patients. Journal
of Nephrology, 17(6), 841–850.
Ashby, M., Op’t Hoog, C., Kelleher, A., Kerr, P. G., Brooks, D., Nicholls,
K., & Forrest, M. (2005). Renal dialysis abatement: Lessons from a
social study. Palliative Medicine, 19, 389–396. https://doi.org/10.
1191/0269216305pm1043oa
Ashing-Giwa, K. T., Padilla, G., Tejero, J., Kraemer, J., Wright, K., Coscar-
elli, A., . . . Hills, D. (2004). Understanding the breast cancer experi-
ence of women: A qualitative study of African American, Asian
10 | JONES ET AL.
American, Latina and Caucasian cancer survivors. Psycho-Oncology,
13(6), 408–428. https://doi.org/10.1002/pon.750
Auer, J. (2002). Dialysis—a family matter. A personal tribute to the rela-
tives of kidney patients. EDTNA/ERCA Journal, 28(3), 141–144.
https://doi.org/10.1111/j.1755-6686.2002.tb00229.x
Baraz, S., Parvardeh, S., Mohammadi, E., & Broumand, B. (2010). Dietary
and fluid compliance: An educational intervention for patients having
haemodialysis. Journal of Advanced Nursing, 66(1), 60–68. https://doi.
org/10.1111/j.1365-2648.2009.05142.x
Bristowe, K., Horsley, H. L., Shepherd, K., Brown, H., Carey, I., Matthews,
B., . . . Murtagh, F. E. (2015). Thinking ahead–the need for early
Advance Care Planning for people on haemodialysis: A qualitative
interview study. Palliative Medicine, 29, 443–450.
Buchman, A. S., Tanne, D., Boyle, P. A., Shah, R. C., Leurgans, S. E., &
Bennett, D. A. (2009). Kidney function is associated with the rate of
cognitive decline in the elderly. Neurology, 73, 920–927. https://doi.
org/10.1212/WNL.0b013e3181b72629
Chilcot, J., Wellstead, D., Da Silva-Gane, M., & Farrington, K. (2008).
Depression on dialysis. Nephron Clinical Practice, 108, 256–264.
https://doi.org/10.1159/000124749
Christensen, A. J., Turner, C. W., Smith, T. W., Holman, J. M., & Gregory,
M. C. (1991). Health locus of control and depression in end-stage
renal disease. Journal of Consulting and Clinical Psychology, 59(3), 419.
https://doi.org/10.1037//0022-006X.59.3.419
Cicolini, G., Palma, E., Simonetta, C., & Di Nicola, M. (2012). Influence of
family carers on haemodialyzed patients’ adherence to dietary and fluid
restrictions: An observational study. Journal of Advanced Nursing, 68
(11), 2410–2417. https://doi.org/10.1111/j.1365-2648.2011.05935.x
Curtin, R. B., & Mapes, D. L. (2001). Health care management strategies
of long-term dialysis survivors. Nephrology Nursing Journal: Journal of
the American Nephrology Nurses’ Association, 28(4), 385.
Denhaerynck, K., Manhaeve, D., Dobbels, F., Garzoni, D., Nolte, C., &
De Geest, S. (2007). Prevalence and consequences of nonadherence
to hemodialysis regimens. American Journal of Critical Care 16, 222–
235.
Denzin, N. K., & Lincoln, Y. S. (1994). Handbook of qualitative research.
Thousand Oaks, CA: Sage Publications, Inc.
Elias, M. F., Elias, P. K., Seliger, S. L., Narsipur, S. S., Dore, G. A., & Rob-
bins, M. A. (2009). Chronic kidney disease, creatinine and cognitive
functioning. Nephrology Dialysis Transplantation, 24, 2446–2452.
https://doi.org/10.1093/ndt/gfp107
Etgen, T., Sander, D., Chonchol, M., Briesenick, C., Poppert, H., Forstl, H.,
& Bickel, H. (2009). Chronic kidney disease is associated with inci-
dent cognitive impairment in the elderly: The INVADE study. Nephrol-
ogy Dialysis Transplantation, 24, 3144–3150. https://doi.org/10.1093/
ndt/gfp230
Fereday, J., & Muir-Cochrane, E. (2006). Demonstrating rigor using the-
matic analysis: A hybrid approach of inductive and deductive coding
and theme development. International Journal of Qualitative methods,
5(1), 80–92. https://doi.org/10.1177/160940690600500107
Franz, M., Pohanka, E., Tribl, B., Woloszczuk, W., & H€orl, W. H. (1997).
Living on chronic hemodialysis between dryness and fluid overload.
Kidney International Supplement, 59, S39–S42.
Griva, K., Newman, S. P., Harrison, M. J., Hankins, M., Davenport, A.,
Hansraj, S., & Thompson, D. (2003). Acute neuropsychological
changes in hemodialysis and peritoneal dialysis patients. Health Psy-
chology, 22, 570–578. https://doi.org/10.1037/0278-6133.22.6.570
Griva, K., Thompson, D., Jayasena, D., Davenport, A., Harrison, M., &
Newman, S. P. (2006). Cognitive functioning pre-to post-kidney
transplantation—a prospective study. Nephrology Dialysis Transplanta-
tion, 21(11), 3275–3282. https://doi.org/10.1093/ndt/gfl385
Hagren, B., Pettersen, I.-M., Severinsson, E., Luetzen, K., & Clyne, N.
(2001). The haemodialysis machine as a lifeline: Experiences of suf-
fering from end-stage renal disease. Journal of Advanced Nursing, 34
(2), 196–202. https://doi.org/10.1046/j.1365-2648.2001.01745.x
Hagren, B., Pettersen, I.-M., Severinsson, E., Luetzen, K., & Clyne, N.
(2005). Maintenance haemodialysis: Patients’ experiences of their life
situation. Journal of Clinical Nursing, 14, 294–300. https://doi.org/10.
1111/j.1365-2702.2004.01036.x
Hart, R. P., & Kreutzer, J. S. (1988). Renal system. In R. E. Tarter, D. H.
Van Thiel, & K. L. Edwards (Eds.), Medical neuropsychology: The impact
of disease on behaviour (pp. 99–120). New York, NY: Plenum Press.
Jaeger, J. Q., & Mehta, R. L. (1999). Assessment of dry weight in
hemodialysis: An overview. Journal of the American Society of Nephrol-
ogy, 10(2), 392–403.
Jassal, S. V., Devins, G. M., Chan, C. T., Bozanovic, R., & Rourke, S.
(2006). Improvements in cognition in patients converting from thrice
weekly hemodialysis to nocturnal hemodialysis: A longitudinal pilot
study. Kidney International, 70, 956–962. https://doi.org/10.1038/
sj.ki.5001691
Johansen, K. L., Chertow, G. M., Ng, A. V., Mulligan, K., Carey, S.,
Schoenfeld, P. Y., & Kent-Braun, J. A. (2000). Physical activity levels
in patients on hemodialysis and healthy sedentary controls. Kidney
International, 57(6), 2564–2570. https://doi.org/10.1046/j.1523-175
5.2000.00116.x
Jones, D. J. W., Butler, L. T., Harris, J. P., & Vaux, E. C. (2015a). Latent
learning in end stage renal disease (ESRD). Physiology and Behaviour,
142, 42–47. https://doi.org/10.1016/j.physbeh.2015.01.033
Jones, D. J. W., Harris, J. P., Vaux, E., Hadid, R., Kean, R., & Butler, L. T.
(2015b). The nature of impairments of memory in patients with end-
stage renal disease (ESRD). Physiology & Behaviour, 147, 324–333.
https://doi.org/10.1016/j.physbeh.2015.05.008
Joshi, V. D. (2014). Quality of life in end stage renal disease. World Jour-
nal of Nephrology, 3(4), 308–316.
Kalantar-Zadeh, K., & Kopple, J. D. (2001). Relative contributions of
nutrition and inflammation to clinical outcome in dialysis patients.
American Journal of Kidney Diseases, 38(6), 1343–1350. https://doi.
org/10.1053/ajkd.2001.29250
Kalender, B., Ozdemir, A. C., Dervisoglu, E., & Ozdemir, O. (2007). Quality of
life in chronic kidney disease: Effects of treatment modality, depression,
malnutrition and inflammation. International Journal of Clinical Practice,
61, 569–576. https://doi.org/10.1111/j.1742-1241.2006.01251.x
Karamanidou, C., Weinman, J., & Horne, R. (2014). A qualitative study of
treatment burden among haemodialysis recipients. Journal of Health Psy-
chology, 19(4), 556–569. https://doi.org/10.1177/1359105313475898
Karamanoli, E. (2011). Debt crisis strains Greece’s ailing health system.
The Lancet, 378(9788), 303–304. https://doi.org/10.1016/S0140-
6736(11)61152-5
Kimmel, P. L., Thamer, M., Richard, C. M., & Ray, N. F. (1998). Psychiatric
illness in patients with end-stage renal disease. The American Journal
of Medicine, 105(3), 214–221. https://doi.org/10.1016/S0002-9343
(98)00245-9
Kurella, M., Chertow, G. M., Luan, J., & Yaffe, K. (2004). Cognitive impair-
ment in chronic kidney disease. American Geriatrics Society, 52, 1863–
1869. https://doi.org/10.1111/j.1532-5415.2004.52508.x
Liu, H. E. (2006). Fatigue and associated factors in hemodialysis patients
in Taiwan. Research in Nursing & Health, 29(1), 40–50. https://doi.
org/10.1002/nur.20109
Locatelli, F., Fouque, D., Heimburger, O., Dr€ueke, T. B., Cannata-Andıa, J.
B., H€orl, W. H., & Ritz, E. (2002). Nutritional status in dialysis
patients: A European consensus. Nephrology Dialysis Transplantation,
17(4), 563–572. https://doi.org/10.1093/ndt/17.4.563
Lopes, A. A., Bragg, J., Young, E., Goodkin, D., Mapes, D., Combe, C., . . .
Port, F. K. (2002). Dialysis Outcomes and Practice Patterns Study
(DOPPS): Depression as a predictor of mortality and hospitalization
among hemodialysis patients in the United States and Europe. Kidney
International, 62(1), 199–207. https://doi.org/10.1046/j.1523-1755.
2002.00411.x
Lynch, E. B., Butt, Z., Heinemann, A., Victorson, D., Nowinski, C. J., Perez,
L., & Cella, D. (2008). A qualitative study of quality of life after
JONES ET AL. | 11
stroke: The importance of social relationships. Journal of Rehabilitation
Medicine, 40(7), 518–523. https://doi.org/10.2340/16501977-0203
Madan, P., Kalra, O. P., Agarwal, S., & Tandon, O. P. (2007). Cognitive
impairment in chronic kidney disease. Nephrology Dialysis Transplanta-
tion, 22(2), 440–444.
Martin, C. R., Tweed, A. E., & Metcalfe, M. S. (2004). A psychometric
evaluation of the Hospital Anxiety and Depression Scale in patients
diagnosed with end-stage renal disease. British Journal of Clinical Psy-
chology, 43, 51–64. https://doi.org/10.1348/014466504772812968
McKevitt, C., Redfern, J., Mold, F., & Wolfe, C. (2004). Qualitative studies
of stroke a systematic review. Stroke, 35(6), 1499–1505. https://doi.
org/10.1161/01.STR.0000127532.64840.36
Moist, L. M., Bragg-Gresham, J. L., Pisoni, R. L., Saran, R., Akiba, T.,
Jacobson, S. H., . . . Port, F. K. (2008). Travel time to dialysis as a pre-
dictor of health-related quality of life, adherence, and mortality: The
Dialysis Outcomes and Practice Patterns Study (DOPPS). American
Journal of Kidney Diseases, 51(4), 641–650. https://doi.org/10.1053/
j.ajkd.2007.12.021
Morduchowicz, G., Sulkes, J., Aizic, S., Gabbay, U., Winkler, J., & Boner,
G. (1993). Compliance in hemodialysis patients: A multivariate regres-
sion analysis. Nephron, 64(3), 365–368. https://doi.org/10.1159/
000187355
Morris, A., Biggerstaff, D., & Lycett, D. (2016). Capturing whole patient
care. Journal of Renal Care, 42(2), 71–72. https://doi.org/10.1111/
jorc.12158
Morton, R. L., Devitt, J., Howard, K., Andersson, K., Snelling, P., & Cass,
A. (2010a). Patient views about treatment of Stage 5 CKD: A qualita-
tive analysis of semistructured interviews. American Journal of Kidney
Disease, 55(3), 431–440. https://doi.org/10.1053/j.ajkd.2009.11.011
Morton, R. L., Tong, A., Howard, K., Snelling, P., & Webster, A. C.
(2010b). The views of patients and carers in treatment decision mak-
ing for chronic kidney disease: Systematic review and thematic syn-
thesis of qualitative studies. British Medical Journal, 340, https://doi.
org/10.1136/bmj.c112
Murray, A. M., Pederson, S. L., Tupper, D. E., Hochhalter, A. K., Miller, W.
A., Qi Li, M. S., . . . Foley, R. N. (2007). Acute variation in cognitive
function in hemodialysis patients: A cohort study with repeated mea-
sures. American Journal of Kidney Diseases, 50(2), 270–278. https://d
oi.org/10.1053/j.ajkd.2007.05.010
Norris, K. C., & Agodoa, L. Y. (2005). Unravelling the racial disparities
associated with kidney disease. Kidney International, 68(3), 914–924.
https://doi.org/10.1111/j.1523-1755.2005.00485.x
Petrie, K. J., & Weinman, J. (2012). Patients’ perceptions of their illness:
The dynamo of volition in health care. Current Directions in Psycholog-
ical Science, 21, 60–65. https://doi.org/10.1177/0963721411429456
Rodriguez, R. A., Sen, S., Mehta, K., Moody-Ayers, S., Bacchetti, P., &
O’Hare, A. M. (2007). Geography matters: Relationships among urban
residential segregation, dialysis facilities, and patient outcomes.
Annals of Internal Medicine, 146(7), 493–501. https://doi.org/10.
7326/0003-4819-146-7-200704030-00005
Rubin, R. R., & Peyrot, M. (1999). Quality of life and diabetes. Diabetes/
Metabolism Research and Reviews, 15(3), 205–218. https://doi.org/10.
1002/(SICI)1520-7560(199905/06)15:3<205:AID-DMRR29>3.0.
CO;2-O
Soskolne, V., & De-Nour, A. K. (1987). Psychosocial adjustment of home
hemodialysis, continuous ambulatory peritoneal dialysis and hospital
dialysis patients and their spouses. Nephron, 47(4), 266–273.
https://doi.org/10.1159/000184522
Spiers, J., & Smith, J. A. (2016). Waiting for a kidney from a deceased
donor: an interpretative phenomenological analysis. Psychology,
Health & Medicine, 21, 836–844. https://doi.org/10.1080/13548506.
2015.1112415
Steeman, E., Casterle, D., Dierckx, B., Godderis, J., & Grypdonck, M.
(2006). Living with early-stage dementia: A review of qualitative
studies. Journal of Advanced Nursing, 54(6), 722–738. https://doi.org/
10.1111/j.1365-2648.2006.03874.x
Strauss, A., & Corbin, J. (1994). Grounded theory methodology. Handbook
of Qualitative Research, 17, 273–285.
Theofilou, P., Synodinou, C., & Panagiotaki, H. (2013). Undergoing
haemodialysis: A qualitative study to investigate the lived experiences
of patients. Europe’s Journal of Psychology, 9(1), 19–32.
Thomas, C., Morris, S. M., & Harman, J. C. (2002). Companions through
cancer: The care given by informal carers in cancer contexts. Social
Science & Medicine, 54(4), 529–544. https://doi.org/10.1016/S0277-
9536(01)00048-X
Thornton, W. L., Shapiro, R. J., Deria, S., Gelb, S., & Hill, A. (2007). Differ-
ential impact of age on verbal memory and executive functioning in
chronic kidney disease. Journal of International Neuropsychological
Society, 13, 344–353. https://doi.org/10.1017/S1355617707070361
Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for
reporting qualitative research (COREQ): A 32-item checklist for inter-
views and focus groups. International journal for quality in health care,
19(6), 349–357.
Vedhara, K., Cox, N. K., Wilcock, G. K., Perks, P., Hunt, M., Anderson, S.,
. . . Shanks, N. M. (1999). Chronic stress in elderly carers of dementia
patients and antibody response to influenza vaccination. The Lancet,
353(9153), 627–631. https://doi.org/10.1016/s0140-6736(98)
06098-x
Verhallen, A. M., Kooistra, M. P., & van Jaarsveld, B. C. (2007). Cannulat-
ing in haemodialysis: Rope-ladder or buttonhole technique? Nephrol-
ogy Dialysis Transplantation, 22(9), 2601–2604. https://doi.org/10.
1093/ndt/gfm043
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the sup-
porting information tab for this article.
How to cite this article: Jones DJW, Harvey K, Harris JP,
Butler LT, Vaux EC. Understanding the impact of
haemodialysis on UK National Health Service patients’ well-
being: A qualitative investigation. J Clin Nurs. 2017;00:1–12.
https://doi.org/10.1111/jocn.13871
12 | JONES ET AL.
